HIV testing is the necessary first step in reducing infection and interrupting transmission; without it, any efforts at diagnosis and appropriate treatment are severely impaired. But testing acceptance in particular populations has been and remains especially low.
In this issue, Dr. Cedric Bien-Gund from the Division of Infectious Diseases at the University of Pennsylvania analyzes the current literature reporting on the strategies to reach these at high-risk people.
Fellow in Infectious Diseases
Division of Infectious Diseases
Department of Medicine
University of Pennsylvania Perelman School of Medicine
Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland
(she/her/hers)
Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
(he/him/his)
Nurse Educator
Boston Medical Center
Boston, MA
(he/him/his)
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: July 9, 2020
Expiration date: July 8, 2022